Inventor
LEIGHTON HARRY J
US18 patents
⚠️ This page may combine multiple inventors who share the name “LEIGHTON HARRY J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BURROUGHS WELLCOME CO
7 patentsUS4879296ANov 7, 1989
Xanthine derivatives
BURROUGHS WELLCOME CO86 citations96
US4923892AMay 8, 1990
Tricyclic aromatic compounds
BURROUGHS WELLCOME CO87 citations95
US4871865AOct 3, 1989
Tricyclic aromatic compounds
BURROUGHS WELLCOME CO97 citations95
US4981857AJan 1, 1991
Purine Derivatives
BURROUGHS WELLCOME CO23 citations92
US5015647AMay 14, 1991
Method for treating viral infections
BURROUGHS WELLCOME CO12 citations73
US4705854ANov 10, 1987
Phenothiazine compounds
BURROUGHS WELLCOME CO14 citations73
US5017577AMay 21, 1991
Methods for treating viral infection
BURROUGHS WELLCOME CO5 citations62
MILESTONE PHARMACEUTICALS INC
6 patentsUS10010523B2Jul 3, 2018
Short acting phenylalkylamine calcium channel blockers and uses thereof
MILESTONE PHARMACEUTICALS INC4 citations83
US10010524B2Jul 3, 2018
Short acting phenylalkylamine calcium channel blockers and uses thereof
MILESTONE PHARMACEUTICALS INC2 citations72
US10010522B2Jul 3, 2018
Short acting phenylalkylamine calcium channel blockers and uses thereof
MILESTONE PHARMACEUTICALS INC2 citations72
US9737503B2Aug 22, 2017
Short acting phenylalkylamine calcium channel blockers and uses thereof
MILESTONE PHARMACEUTICALS INC2 citations72
US9463179B2Oct 11, 2016
Short acting phenylalkylamine calcium channel blockers and uses thereof
MILESTONE PHARMACEUTICALS INC2 citations61
US9227918B2Jan 5, 2016
Short acting phenylalkylamine calcium channel blockers and uses thereof
MILESTONE PHARMACEUTICALS INC2 citations61